Antipsychotics

Alzheimer’s disease and dementia present profound challenges in cognitive and functional decline among the elderly. While not curative, antipsychotic medications are sometimes used to manage behavioral symptoms like agitation, aggression, and hallucinations that can arise in these conditions. However, their use in dementia care is controversial due to potential side effects, including increased risk of stroke, sedation, and accelerated cognitive decline. Non-pharmacological approaches such as structured routines, cognitive stimulation, and environmental modifications are preferred whenever possible. Careful consideration by healthcare providers is essential, weighing the risks and benefits to ensure the highest quality of life for patients while minimizing adverse effects. Ongoing research aims to refine treatment strategies, emphasizing personalized care approaches tailored to the unique needs and responses of individuals with Alzheimer’s disease and other forms of dementia.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp